Nurse Prescribers with Davis Edge
6th Edition
TEST BANK
Reference: Ch. 1, Section: Roles and Responsibilities —
Prescribing Authority
Question Stem: A 34-year-old APRN working in an outpatient
clinic is asked to start prescribing for patients independently for
the first time. Which action best demonstrates safe, scope-
appropriate prescriptive practice?
Options:
A. Prescribe any noncontrolled medication without
documentation because outpatient protocols allow it.
B. Confirm state regulations and institutional policies, obtain
required collaborative agreements, and document prescriptive
decisions.
C. Refer all medication decisions to the supervising physician to
avoid liability.
D. Prescribe medications based solely on patient requests when
symptoms match previously seen cases.
Correct Answer: B
Rationales:
, • Correct (B): APRN prescribing requires knowledge of state
regulations, institutional policies, and often a collaborative
or supervisory agreement; documenting clinical reasoning
supports safe prescriptive practice. This aligns with the
textbook emphasis on legal/regulatory responsibilities for
prescribers. F. A. Davis+1
• (A) Incorrect: Policies do not remove the need for
documentation or for compliance with scope-of-practice
laws; this is unsafe.
• (C) Incorrect: While collaboration is appropriate where
required, blanket referral removes APRN autonomy and
does not demonstrate correct use of prescriptive authority.
• (D) Incorrect: Prescribing solely on patient request without
assessment and documentation risks inappropriate
therapy and patient harm.
Teaching Point: Verify regulations and document
prescriptive decisions.
Citation: Woo, T. M., & Wright, W. L. (6th ed.), Ch. 1, Roles
and Responsibilities. F. A. Davis+1
2.
Reference: Ch. 1, Section: Legal & Regulatory Considerations —
Controlled Substances
Question Stem: An APRN has a DEA registration and is treating
chronic pain. Which practice best reduces regulatory risk when
,prescribing schedule II opioids?
Options:
A. Prescribe a 90-day supply to improve adherence.
B. Use state PDMP data, document pain assessment and
treatment plan, and schedule regular follow-ups.
C. Delegate opioid prescribing to office staff to manage
workload.
D. Avoid documenting urine drug screens to respect patient
privacy.
Correct Answer: B
Rationales:
• Correct (B): Using prescription drug monitoring programs
(PDMPs), thorough documentation of assessments and
treatment plans, and close follow-up are standard risk-
mitigation strategies highlighted in the chapter. F. A.
Davis+1
• (A) Incorrect: Large supplies of schedule II opioids increase
risk of misuse and often conflict with
guidelines/regulations.
• (C) Incorrect: Prescriptive decisions cannot be delegated to
nonprescribers; delegation of clinical judgment is
inappropriate.
• (D) Incorrect: Urine drug screening can be part of safe
opioid management; omitting it when clinically indicated
may increase risk.
Teaching Point: Use PDMPs, document thoroughly, and
, monitor closely.
Citation: Woo & Wright, Ch. 1, Controlled Substances and
Regulatory Considerations. F. A. Davis+1
3.
Reference: Ch. 1, Section: Patient Safety — Medication
Reconciliation
Question Stem: A patient is admitted to the clinic with a
complex med list from multiple providers. Which immediate
step best reduces the risk of medication errors before the APRN
prescribes a new therapy?
Options:
A. Continue the patient’s home medications without
verification.
B. Perform a structured medication reconciliation, verify
sources, and clarify discrepancies.
C. Stop all home medications until a specialist review is
completed.
D. Rely solely on the patient’s memory of drug names and
doses.
Correct Answer: B
Rationales:
• Correct (B): Medication reconciliation with verification
from reliable sources (labels, pharmacies, records) is a core
safety practice to prevent errors and adverse interactions.